Bone Biologics is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Jeffrey Frelick, with a market cap of $2.0M.
Common questions about Bone Biologics
Bone Biologics is scheduled to report earnings for Q1 2026 on May 11, 2026.
Bone Biologics has approximately 2 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.